Efficacy of siltuximab in the treatment of idiopathic multicentric castleman disease, the first Polish, real-world experience with long-term observation
Beata Ostrowska, Agnieszka Szymczyk, Magdalena Olszewska‐Szopa, Joanna Romejko‐Jarosińska, Katarzyna Domańska‐Czyż, Anna Dąbrowska‐Iwanicka, Waldemar Tomczak, Sebastian Rybski, Marek Hus, Tomasz Wróbel, Jan Walewski
Abstract
(2021). Efficacy of siltuximab in the treatment of idiopathic multicentric castleman disease, the first Polish, real-world experience with long-term observation. Leukemia & Lymphoma: Vol. 62, No. 12, pp. 3031-3034.
Topics & Concepts
MedicineDiseaseTerm (time)Castleman diseasePediatricsInternal medicinePhysicsQuantum mechanicsLymphoma Diagnosis and TreatmentViral-associated cancers and disordersChronic Lymphocytic Leukemia Research